KMT2D and diffuse large B-cell lymphoma: However, previous work ruled out LSD1 as the KMT2D antagonist in DLBCL and FL cells, since specific inhibitors against this protein do not revert silencing of KMT2D target genes nor cause any kind of proliferation arrest or differentiation in DLBCL cells (Hatzi et al., 2019).